CGEM Filings — Cullinan Therapeutics, Inc.

FilingSpy

CGEM Filings — Cullinan Therapeutics, Inc. - FilingSpy

Insiders trading · 1Y

5 selling · 1 buying

Bought · 1Y

1.87M

8 open-market buys

Sold · 1Y

119.9K

25 open-market sales

Own-timing sales

72.5K

of 119.9K sold

Insiders

Ranked by how much each holding moved in the last year

Lynx1 Capital Management LP +1 co-filer10% owner · 8 transactions

8.96M—

Bought 1.87M

Ahmed NadimPresident and CEO, Director · 3 transactions

390.8K-9.2%

Sold 39.8K

Michaelson JenniferChief Scientific Officer · 19 transactions

174.8K+23.1%

Granted 73.5K · Sold 50.7K

Jones Jeffrey AlanChief Medical Officer · 3 transactions

160.0K-8.2%

Sold 14.2K

Sumer Jacquelyn LChief Legal Officer · 3 transactions

128.1K-6.4%

Sold 10.8K

Fenton Mary KayChief Financial Officer · 3 transactions

126.4K+110.6%

Granted 68.8K · Sold 4.4K

Insider	Stake change	Holds now	Granted / vested	Bought	Sold
Lynx1 Capital Management LP +1 co-filer10% owner · 8 transactions	—	8.96M	—	1.87M	—
Ahmed NadimPresident and CEO, Director · 3 transactions	-9.2%	390.8K	—	—	39.8K
Michaelson JenniferChief Scientific Officer · 19 transactions	+23.1%	174.8K	73.5K	—	50.7K
Jones Jeffrey AlanChief Medical Officer · 3 transactions	-8.2%	160.0K	—	—	14.2K
Sumer Jacquelyn LChief Legal Officer · 3 transactions	-6.4%	128.1K	—	—	10.8K
Fenton Mary KayChief Financial Officer · 3 transactions	+110.6%	126.4K	68.8K	—	4.4K

Select a row to see that insider’s individual transactions.

Net open-market activity over the last year: +1.75M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.